1. Home
  2. SMC vs ALLO Comparison

SMC vs ALLO Comparison

Compare SMC & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMC
  • ALLO
  • Stock Information
  • Founded
  • SMC 2009
  • ALLO 2017
  • Country
  • SMC United States
  • ALLO United States
  • Employees
  • SMC N/A
  • ALLO N/A
  • Industry
  • SMC
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SMC
  • ALLO Health Care
  • Exchange
  • SMC NYSE
  • ALLO Nasdaq
  • Market Cap
  • SMC 402.7M
  • ALLO 427.7M
  • IPO Year
  • SMC 2012
  • ALLO 2018
  • Fundamental
  • Price
  • SMC $43.35
  • ALLO $2.17
  • Analyst Decision
  • SMC
  • ALLO Strong Buy
  • Analyst Count
  • SMC 0
  • ALLO 10
  • Target Price
  • SMC N/A
  • ALLO $10.06
  • AVG Volume (30 Days)
  • SMC 68.6K
  • ALLO 9.8M
  • Earning Date
  • SMC 03-04-2025
  • ALLO 03-13-2025
  • Dividend Yield
  • SMC N/A
  • ALLO N/A
  • EPS Growth
  • SMC N/A
  • ALLO N/A
  • EPS
  • SMC N/A
  • ALLO N/A
  • Revenue
  • SMC $450,857,000.00
  • ALLO $43,000.00
  • Revenue This Year
  • SMC N/A
  • ALLO N/A
  • Revenue Next Year
  • SMC N/A
  • ALLO N/A
  • P/E Ratio
  • SMC N/A
  • ALLO N/A
  • Revenue Growth
  • SMC 7.80
  • ALLO 26.47
  • 52 Week Low
  • SMC $17.26
  • ALLO $1.32
  • 52 Week High
  • SMC $45.89
  • ALLO $5.78
  • Technical
  • Relative Strength Index (RSI)
  • SMC 55.11
  • ALLO 55.14
  • Support Level
  • SMC $43.10
  • ALLO $1.32
  • Resistance Level
  • SMC $45.38
  • ALLO $3.78
  • Average True Range (ATR)
  • SMC 1.59
  • ALLO 0.36
  • MACD
  • SMC -0.08
  • ALLO 0.10
  • Stochastic Oscillator
  • SMC 51.15
  • ALLO 34.55

About SMC SUMMIT MIDSTREAM CORPORATION

Summit Midstream Corp is a value-driven corporation focused on developing, owning and operating midstream energy infrastructure assets strategically located in unconventional resource basins, primarily shale formations, in the continental U.S. It currently operates natural gas, crude oil and produced water gathering systems in four unconventional resource basins: the Williston Basin in North Dakota, which includes the Bakken and Three Forks shale formations; the Denver-Julesburg Basin, which includes the Niobrara and Codell shale formations in Colorado and Wyoming; the Fort Worth Basin in Texas, which includes the Barnett Shale formation; and the Piceance Basin in Colorado, which includes the liquids-rich Mesaverde formation as well as the emerging Mancos and Niobrara Shale formations.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, primarily generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: